Post
Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn
Deciphera Pharmaceuticals is set to be acquired in a $2.4bn buyout, as the biopharma announced that it has commenced a …
Biodexa gains license for polyposis asset as stock more than doubles
UK-based biopharma company Biodexa has entered into an exclusive licencing agreement with Emtora Biosciences for the rare precancerous condition-treating drug …
“Profound concern” over WHO’s pandemic agreement, says AIDS charity
The AHF Global Public Health Institute has voiced concerns over the World Health Organization’s (WHO) proposed pandemic agreement, saying that …
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
AstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically for the eosinophilic phenotype, in children aged …
BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding
US lawmakers have added more Chinese biotech and medtech companies to the list of firms posing national security risks that …
Duchenne Muscular Dystrophy: the global clinical trials landscape 2024
Impacting approximately 1 in 5,000 males globally, Duchenne Muscular Dystrophy is a rare genetic disorder characterised by progressive muscle weakness …
Sino Biological concludes SignalChem acquisition for $48m
Sino Biological has concluded the acquisition of Canadian biotechnology company SignalChem Biotech (SCB) for $48m in a move that …
PharmaLink partners with Recall Results on safety of drugs
PharmaLink has partnered with Recall Results on an accurate and responsive process for drug recalls, withdrawals and market actions in …
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
Gilead Sciences has received a US Food and Drug Administration (FDA) approval for the label expansion of its human immunodeficiency …
Pierre Fabre’s vibegron gains CHMP positive opinion for OAB
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion and recommended …
Pfizer receives FDA approval for haemophilia B gene therapy
Pfizer has received approval from the US Food and Drug Administration (FDA) for its one-time gene therapy BEQVEZ (fidanacogene elaparvovec-dzkt) …
Cell and gene therapy companies trip at scalability hurdle
In the last few decades, the rise in cell and gene therapy development has brought about several high-profile successes, but …
ESCMID 2024: Using AI in infection prevention and control
At the 34th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global (formerly ECCMID) conference in Barcelona, Spain, the …
Pioneer Institute study finds IRA discourages non-opioid drug innovation
A study from a US-based public policy research firm has highlighted that the US Inflation Reduction Act (IRA) is likely …
The privileged status of orphan medicines in Germany
In Germany, new measures have come into effect as part of the GKV-FinStG Act in 2022 that put into question …